中国CT和MRI杂志
中國CT和MRI雜誌
중국CT화MRI잡지
Chinese Journal of CT and MRI
2015年
12期
102-104
,共3页
前列腺癌%临床分期%CT%MRI
前列腺癌%臨床分期%CT%MRI
전렬선암%림상분기%CT%MRI
Prostatic Cancer%Clinical Staging%CT%MRI
目的：探讨CT及MRI在前列腺癌临床分期中的应用价值差异。方法选取124例经外科手术病理检查确诊的前列腺癌患者为研究对象,均予以术前CT及MRI检查。以术后病理分期结果为“金标准”，评估CT及MRI分期的符合率差异。结果 MRI正确诊断A期18例(78.3%)，B期21例(75.0%)，C期36例(85.7%)，D期27例(87.1%)；CT正确诊断A期10例(43.5%)， B期13例(46.4%)，C期35例(83.3%)，D期26例(83.9%)；两种检查方法在C、D期诊断准确率对比上均无统计学意义(P＞0.05)；A、B期时，MRI分期诊断准确率明显高于CT，差异具有统计学意义(P＜0.05)。结论 MRI检查在A、B期前列腺癌患者的分期准确率较CT检查高，临床可将该检查方案应用于前列腺癌患者的术前分期评估工作中，为治疗方案的拟定提供依据，值得临床推广。
目的：探討CT及MRI在前列腺癌臨床分期中的應用價值差異。方法選取124例經外科手術病理檢查確診的前列腺癌患者為研究對象,均予以術前CT及MRI檢查。以術後病理分期結果為“金標準”，評估CT及MRI分期的符閤率差異。結果 MRI正確診斷A期18例(78.3%)，B期21例(75.0%)，C期36例(85.7%)，D期27例(87.1%)；CT正確診斷A期10例(43.5%)， B期13例(46.4%)，C期35例(83.3%)，D期26例(83.9%)；兩種檢查方法在C、D期診斷準確率對比上均無統計學意義(P＞0.05)；A、B期時，MRI分期診斷準確率明顯高于CT，差異具有統計學意義(P＜0.05)。結論 MRI檢查在A、B期前列腺癌患者的分期準確率較CT檢查高，臨床可將該檢查方案應用于前列腺癌患者的術前分期評估工作中，為治療方案的擬定提供依據，值得臨床推廣。
목적：탐토CT급MRI재전렬선암림상분기중적응용개치차이。방법선취124례경외과수술병리검사학진적전렬선암환자위연구대상,균여이술전CT급MRI검사。이술후병리분기결과위“금표준”，평고CT급MRI분기적부합솔차이。결과 MRI정학진단A기18례(78.3%)，B기21례(75.0%)，C기36례(85.7%)，D기27례(87.1%)；CT정학진단A기10례(43.5%)， B기13례(46.4%)，C기35례(83.3%)，D기26례(83.9%)；량충검사방법재C、D기진단준학솔대비상균무통계학의의(P＞0.05)；A、B기시，MRI분기진단준학솔명현고우CT，차이구유통계학의의(P＜0.05)。결론 MRI검사재A、B기전렬선암환자적분기준학솔교CT검사고，림상가장해검사방안응용우전렬선암환자적술전분기평고공작중，위치료방안적의정제공의거，치득림상추엄。
Objective To investigate the differences in the application value of CT and MRI in the clinical staging of prostaticcancer.Methods 124 patients with prostaticcancer comfirmed by surgical and pathological examination who were treated in the hospital during June 2012 to April 2015 were selected as the research objects.All of them received CT and MRI examination before operation. The results of the examinations weredetailedly recorded and analyzed. The results of postoperative pathological staging were taken as the gold standard to evaluate the differences in coincidence rates of CT and MRI staging.Results The results of surgical and pathological staging showed that among the 124 patients with prostaticcancer, there were 23 cases at stage A(18.5%), 28 cases at stage B(22.6%), 42 cases at stage C(33.9%) and 31 cases at stage D(25.0%). Taking the results of surgical and pathological staging as the gold standard, it indicated that there were 18 cases at stage A(78.3%), 21 cases at stage B(75.0%), 36 cases at stage C(85.7%) and 27 cases at stage D(87.1%) correctly diagnosed by MRI. There were 10 cases at stage A(43.5%), 13 cases at stage B(46.4%), 35 cases at stage C(83.3%) and 26 cases at stage D(83.9%)correctly diagnosed by CT. There was no statistical significance in the comparison of accuracy at stage C and D between the two methods(P>0.05). At stage A and B, the diagnostic accuracy of MRI staging was significantly higher than that of CT and the difference was statistically significant (P<0.05).Conclusion The staging accuracy of MRI examination in patients with prostaticcancer at stage A and B was higher than that of CT, which can be used in the preoperative staging evaluation of patients with prostatic cancer and provide basis for making treatment plan. It is worthy of promotion.
